Biotech job market 2024: what to expect?
The past year saw pipeline cuts and downsizing plans strike the biotech industry. Does the biotech job market seem to be looking up this year?| Labiotech.eu
As a recent approval closes a major therapeutic gap, let’s take a look at some of the latest progress and new treatments against malaria. The post How are biotechs tackling malaria? appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech ...| Labiotech.eu
Kriya Therapeutics, Strand Therapeutics, and Minghui Pharmaceutical bagged the biggest biotech funding rounds overall in August 2025. The post The biggest biotech funding rounds in August 2025 appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Lab...| Labiotech.eu
As September marks the beginning of Blood Cancer Awareness Month, delve into what is being developed in the biotech pipelines. The post Blood Cancer Awareness Month: What biotech holds in store appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to ...| Labiotech.eu
Find out whether genetically modified crops can help us adapt to climate change and ensure global food security. The post Can genetically modified crops help us adapt to climate change? appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech ...| Labiotech.eu
Our guest this week is Antti Vuolanto, CEO of Herantis Pharma, and we discussed the science behind their approach, and the advantages and challenges of working in biotech in the Nordics. The post A Finnish biotech is making progress on Parkinson’s disease with support from The Michael J. Fox Foundation appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or ...| Labiotech.eu
Find out about ExCellThera's zemcelpro, the first blood cord expansion therapy to reach the European market, and only the second globally. The post Zemcelpro, the first blood cord expansion therapy to reach the EU market appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full an...| Labiotech.eu
Discover five South Korean biotechs that have received funding in recent years and are broadening R&D in various therapeutics areas. The post Five biotech companies in South Korea you should know about appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is giv...| Labiotech.eu
Find out what Sanofi has been up to in 2025, especially as it just closed the Opella deal and is now expanding its pipeline. The post The Sanofi pipeline in 2025: Is the play-to-win strategy working? appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is g...| Labiotech.eu
Our guest this week is Paul Nioi, Senior Vice President of Research at Alnylam and we talked about the evolution of RNAi. The post How RNAi is expanding from a therapy of choice for rare disease into treating common conditions appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that ful...| Labiotech.eu
Get the latest news on the applications of Artificial Intelligence (AI) and machine learning in drug discovery, healthcare, agriculture, and more.| Labiotech.eu
The past year saw pipeline cuts and downsizing plans strike the biotech industry. Does the biotech job market seem to be looking up this year?| Labiotech.eu
As the biotech industry flourishes, drug developers need to interact increasingly with patient organizations, especially in the rare disease space.| Labiotech.eu
Unlock exclusive career opportunities in biotech and biopharma with our curated list of top life sciences job boards.| Labiotech.eu
Biotech startups are a high-risk venture. Experts explain what the most common reasons for failure are and what can be done to avoid them.| Labiotech.eu
Funding a biotech startup can be challenging. Delve into our guide to navigate this complicated investment landscape.| Labiotech.eu
Mission statement, purpose and vision are essential to the success of a biotech. Delve into the stategies to build on company culture.| Labiotech.eu
By Varvara Melikhova, founder and CEO of Unison Innovations Strategic partnerships are a better way to build a product’s capabilities than outright acquisitions. While the M&A path is set out for the most mature successful startups, early-stage partnerships can enhance a product’s market value and provide access to Big Pharma expertise and infrastructure, which significantly […]| Labiotech.eu
The last month has seen several big investments in European neuromodulation and neurostimulation companies, which aim to treat neurological conditions by zapping nerve cells. What's the reason for this funding peak?| Labiotech.eu
Since the Hormone Replacement Therapy market was destroyed almost overnight in 2002, there has been a lot of caution about investing in companies with a focus on women’s health. Mary Kerr, CEO of KaNDy Therapeutics and NeRRe Therapeutics, knows this only too well, but has not let it deter her in her quest to bring a treatment for symptoms of the menopause to the market.| Labiotech.eu
Many biotech entrepreneurs dread the possibility of investors taking control in a situation that resembles a hostile takeover. But it needn't be that way.| Labiotech.eu
Building a biotech startup can be a daunting task and often founders rely on incubators - but how to choose the right one?| Labiotech.eu
Sabine Dandiguian, Managing Partner at the life sciences VC firm Jeito Capital, shares her experience building a thriving company culture.| Labiotech.eu
What's my business model? Who do I partner with? How do I scale up? These are typical strategic questions a young biotech will regularly face.| Labiotech.eu
Explore our articles offering advice and consulting on various aspects of the biotech industry, from strategic planning to market analysis and partnerships.| Labiotech.eu
To honor International Women's Day, we asked female biotech leaders for their tips on how to encourage women in the life sciences industry.| Labiotech.eu
Get the latest biotech news for Europe, including the latest research, partnerships, regulations, and technology advancements.| Labiotech.eu
Hiring is a big challenge in biotech; life sciences recruitment experts share their strategies for attracting and retaining talent in the biotech industry.| Labiotech.eu
As new measures are being developed to spur quicker and efficient diagnoses, here are six molecular diagnostics companies to look out for.| Labiotech.eu
Here is a list of 14 biotech podcasts to keep you up to date with the latest advances in the biotechnology industry.| Labiotech.eu
Here’s a list of the 15 public European biotech companies that are worth more than a billion euros in 2022.| Labiotech.eu
To commemorate Lupus Awareness Month in May, here are five advancements in lupus research over the past year.| Labiotech.eu
As we celebrate International Women’s Day, here are 5 women who are leading the way in research and innovation in the biotech industry!| Labiotech.eu
Nature writes the best horror stories – In The New York Times’ recent piece, the return of the screwworm, a flesh‑eating parasite once eradicated from the U.S. Indeed, cattle ranchers are once again staring at wounds riddled with maggots. This insect, which devastated cattle in the 20th century, is making a comeback, spurring governments to […] The post From pasture to lab: The new biotech toolkit for cattle appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthori...| Labiotech.eu
Take a look at some of the top biotech companies you can find in Spain, whose biotech industry has grown dramatically in the last decade. The post 10 biotech companies you should know about in Spain appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given ...| Labiotech.eu
The U.S. government announced funding cuts to mRNA vaccine research. What is the impact on American healthcare and biotech? The post mRNA vaccine funding cuts: the impact on U.S. healthcare and biotech appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is g...| Labiotech.eu
Discover how melanoma vaccines are gaining traction in the clinic and could soon become a treatment option for this deadly skin cancer.| Labiotech.eu
The companies Candid Therapeutics, ArsenalBio, and eGenesis bagged the biggest private biotech investments in September 2024.| Labiotech.eu
The companies Treeline Biosciences, Kailera Therapeutics, and Seaport Therapeutics bagged the biggest private biotech investments in October 2024.| Labiotech.eu
The companies Uniquity Bio, AltruBio, and BridgeBio Oncology Therapeutics bagged the biggest private biotech investments in May 2024.| Labiotech.eu
The companies Formation Bio, Isotopen Technologien München, and Marea Therapeutics bagged the biggest private biotech investments in June 2024.| Labiotech.eu
The companies Xaira Therapeutics, Metsera, and Obsidian Therapeutics bagged the biggest private biotech investments in April 2024.| Labiotech.eu
Discover why some biotechs fail but survive with cash on hand, and how players like Concentra are trying to unlock trapped capital.| Labiotech.eu
Abivax, MapLight Therapeutics, Everest Medicines, and Soleno Therapeutics bagged the biggest biotech funding rounds overall in July 2025.| Labiotech.eu
New narcolepsy treatments are being tested in the clinic, and recently, some of them have made promising strides. How far along are they?| Labiotech.eu
Discover Denmark's dynamic biotech scene with 10 innovative companies at the forefront of the biopharmaceutical revolution!| Labiotech.eu
Learn how Deep Science Ventures’ zero-data approach tackles biotech’s early funding challenges to speed innovation and reduce risk.| Labiotech.eu
NATO Innovation Fund backs Portal Biotech in its first biotech move. What does this signal for strategic investment in healthcare innovation?| Labiotech.eu
XOMA Royalty’s acquisition of Turnstone Biologics highlights how royalty deals can revive biopharma companies and drive industry innovation.| Labiotech.eu
Labiotech.eu covers the global biotech industry, read by 150,000+ monthly visitors. Hope you'll enjoy our Biotech News!| Labiotech.eu
From groundbreaking immunotherapies to AI diagnostics and new vaccines, explore the innovations shaping the future of cancer treatment.| Labiotech.eu
Australia's bet is to keep its biotech landscape innovative throught R&D tax incentives. Delve into their strategy and its results.| Labiotech.eu
Read more to find out what role ChatGPT has to play in the drug discovery process within the life sciences industry.| Labiotech.eu
A spate of royalty deals are changing the way certain biotechs press ahead, as seen with Cytokinetics’ agreement with Royalty Pharma.| Labiotech.eu
Plastic is the staple material of modern life, and a sustainable future will need bioplastics. What is Biotech doing to make this happen?| Labiotech.eu
Explore the intricate world of the biotech industry, delving deep into current trends and challenges through our collection of in-depth analysis articles.| Labiotech.eu
Find out how CAR-T cell therapy, which has been so groundbreaking in treating blood cancers, could potentially cure glioblastoma.| Labiotech.eu
Get the latest biotech news for Career, including the latest research, partnerships, regulations, and technology advancements.| Labiotech.eu
Discover expert advice from recruiters on crafting a standout biotech resume that grabs employers' attention and lands you interviews.| Labiotech.eu
Check out five important biotechnology careers that are currently in high demand, and likely still will be in the coming years.| Labiotech.eu
Building a career in biotech can be a daunting task without the right skills. Delve into the strategies to improve and leverage them.| Labiotech.eu
Alan Levy shares his experience on how to make the relationship between the board and the CEO of a life sciences company work.| Labiotech.eu
Find the top upcoming international biotech conferences, events, seminars, webinars, and workshops for 2024!| Labiotech.eu
Here is a list of ten recruiters in the biotech space, nominated by our readers, who are making strides in the life science sector.| Labiotech.eu
The companies Metsera, Alentis Therapeutics, and Adcendo bagged the biggest private biotech investments in November 2024.| Labiotech.eu
The companies Cardurion Pharmaceuticals, Beacon Therapeutics, and Third Arc Bio bagged the biggest private biotech investments in July 2024.| Labiotech.eu
The companies Borealis Biosciences, Outpace Bio, and Halda Therapeutics bagged the biggest private biotech investments in August 2024.| Labiotech.eu
The companies Immunovant, Verdiva Bio, and Akero Therapeutics bagged the biggest biotech funding rounds overall in January 2025.| Labiotech.eu
Get the latest biotech news for USA, including the latest research, partnerships, regulations, and technology advancements.| Labiotech.eu
Get the latest biotech news for United Kingdom, including the latest research, partnerships, regulations, and technology advancements.| Labiotech.eu
Get the latest biotech news for China, including the latest research, partnerships, regulations, and technology advancements.| Labiotech.eu
Those are our privacy policies, showing you how we respect your privacy and your data, so we all live in a happy and non-spammy world :)| Labiotech.eu
The month of December 2024 saw a variety of biotech deals take place to advance therapies across different stages in development.| Labiotech.eu
The companies Nuvig Therapeutics, Ottimo Pharma, and Angitia Biopharmaceuticals bagged the biggest private biotech investments in December 2024.| Labiotech.eu
GSK took center stage last month, forming standout partnerships and alliances across multiple therapeutic areas.| Labiotech.eu
The emerging spatial transcriptomics field is letting researchers map out gene expression in tumor and brain samples. How could this change the way we treat disease?| Labiotech.eu
In this article, we take a look at eight biotechs that have acquired funding in recent years to fortify their GPCR-focused pipelines.| Labiotech.eu
Take a look at six multiple sclerosis companies trying to make a difference to patients by advancing new treatments for the CNS disease.| Labiotech.eu
Here are eight nanotechnology companies that are widening the scope in medicine, that you should know about.| Labiotech.eu
Find out more about six biomimicry companies harnessing nature’s wisdom to create drug candidates for the benefit of human health.| Labiotech.eu
Stay informed about the latest clinical trial news, inlcuding the outcomes of ongoing clinical trials, new innovative trial methodologies, and more!| Labiotech.eu
Eisai and Biogen have announced that the FDA has approved LEQEMBI 100 mg/mL injection for intravenous use for treating Alzheimer's disease.| Labiotech.eu
Get the latest news related to Alzheimer's, including the latest research, partnerships, and technology advancements of alzheimer's biotech companies.| Labiotech.eu
Learn more about Biogen's strategic realignment from Aduhelm's controversy to Leqembi's promise in Alzheimer's treatment.| Labiotech.eu
As we observe Alzheimer's & Brain Awareness Month in June, here are six recent advancements that could transform Alzheimer's research.| Labiotech.eu
Get the latest biotech news for Immunotherapy, including the latest research, partnerships, regulations, and technology advancements.| Labiotech.eu
Get the latest biotech news for Cancer, including the latest research, partnerships, regulations, and technology advancements.| Labiotech.eu
mRNA vaccines have been used for cancer therapies as well as for protection from infectious diseases, particularly for COVID-19.| Labiotech.eu
Discover promising advancements in oncology clinical trials presented by experts and biotechs from around the globe at ASCO 2024.| Labiotech.eu
Get the latest biotech news for GPCR, including the latest research, partnerships, regulations, and technology advancements.| Labiotech.eu
Get the latest biotech news for Antibodies, including the latest research, partnerships, regulations, and technology advancements.| Labiotech.eu
Take a closer look at how the obesity drug market is currently soaring after the success of new weight loss drugs like Wegovy.| Labiotech.eu
GLP-1 agonists have been on the radar for a while to treat diabetes and obesity. And of late, there has been renewed interest in these drugs.| Labiotech.eu
Get the latest biotech news for investment, including the latest research, partnerships, regulations, and technology advancements.| Labiotech.eu
Get the latest biotech news for Funding, including the latest research, partnerships, regulations, and technology advancements.| Labiotech.eu
The coronavirus pandemic is creating big swings in the public market. What sort of impact will Covid-19 have on biotech stocks?| Labiotech.eu
On its way to tackle cancer therapy resistance with its monoclonal antibody visugromab, CataLym completes a $150 million series D round.| Labiotech.eu
Explore five leading bioinformatics companies driving biopharma innovation in 2024 with advanced computer technology.| Labiotech.eu
Discover how multivariate analysis is transforming target identification in cancer drug discovery by moving beyond traditional methods.| Labiotech.eu
Uncover the promise of KRAS inhibitors in cancer treatment, as evidenced by a $200 million investment in BridgeBio's spinout.| Labiotech.eu
The companies Mirador Therapeutics, Alumis, and Sionna Therapeutics bagged the biggest private biotech investments in March 2024.| Labiotech.eu
